2014, Número 2
Tratamiento quirúrgico de la diabetes mellitus tipo 2
Carrillo-Esper R, Muciño-Bermejo MJ
Idioma: Español
Referencias bibliográficas: 38
Paginas: 219-230
Archivo PDF: 448.86 Kb.
RESUMEN
Diversos procedimientos de cirugía bariátrica y otros quirúrgicos gastrointestinales
pueden remitir la diabetes mellitus tipo 2 y disminuir la
hiperlipidemia e hipertensión arterial en pacientes obesos y no obesos.
Está demostrado que en esos pacientes los efectos metabólicos de la cirugía
bariátrica no sólo se reflejan en pérdida de peso e ingesta calórica,
sino también en cambios endocrinos resultantes de la manifestación
quirúrgica del tubo gastrointestinal. Se revisan los resultados clínicos
de esas intervenciones (“cirugía metabólica”) en pacientes con diabetes
mellitus tipo 2 y las perspectivas de su papel en el tratamiento de la
diabetes mellitus tipo 2.
REFERENCIAS (EN ESTE ARTÍCULO)
World Health Organization. Obesity and Overweight. (consultado el 23 de marzo de 2013). Disponible en http:// www.who.int/hpr/NPH/docs/gs_obesity.pdf (2011)
Córdova-Villalobos JA. El Acuerdo Nacional para la Salud Alimentaria como una estrategia contra el sobrepeso y la obesidad. Cir Cir 2010;78:105-107.
Dixon JB, Zimmet P, Alberti KG, Rubino F. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med 2011;28:628-642.
Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339-352.
Friedman MN, Sancetta AJ, Magovern GJ. The amelioration of diabetes mellitus following subtotal gastrectomy. Surg Gynecol Obstet 1955;100:201-204.
Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic Surgery to Treat Type 2 Diabetes: Clinical Outcomes and Mechanisms of Action. Annu Rev Med 2010;61:393-411.
Thaler JP, Cummings DE. Hormonal and Metabolic Mechanisms of Diabetes Remission after Gastrointestinal Surgery. Endocrinology 2009;150:2518-2525.
Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, et al. The Mechanism of Diabetes Control After Gastrointestinal Bypass Surgery Reveals a Role of the Proximal Small Intestine in the Pathophysiology of Type 2 Diabetes. Ann Surg 2006;244:741-749.
Mason EE. Ileal Transposition and Enteroglucagon/GLP-1 in Obesity (and Diabetic?) Surgery Obes Surg 1999;9:223-228.
Frezza EE. Are We Closer in Finding the Treatment for Type 2 Diabetes Mellitus in Morbid Obesity? Are the Incretins the Key to Success? Obes Surg 2004;14:999-1005.
Rubino F, R’bibo SL, del Genio F, Mazumdar M, McGraw TE. Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol 2010;6:102-109. Doi: 10.1038/nrendo.2009.268
Kini S, Herron DM, Yanagisawa RT. Bariatric Surgery for Morbid Obesity: A Cure for Metabolic Syndrome? Med Clin North Am 2007;91:1255-1271.
Arroyo K, Kini SU, Harvey JE, Herron DM. Surgical Therapy for Diabesity. Mt Sinai J Med 2010;77:418-430. Doi: 10.1002/msj.20209
Rubino F, Kaplan LM, Schauer PR, Cummings DE. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg 2010;251:399-405.
American Diabetes Association. Standards of Medical Care in Diabetes-2009. Diabetes Care 2009;32(suppl 1):S13-61.
Dixon JB, Zimmet P, Alberti KG, Rubino F. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med 2011;28:628-642. Doi: 10.1111/j.1464-5491.2011.03306.x
Buchwald H, Oien DM. Metabolic-Bariatric Surgery Worldwide 2008. Obes Surg. 2009;19:1605-1611. Doi: 10.1007/ s11695-009-0014-5
Buchwald H, Williams SE. Bariatric Surgery Worldwide 2003. Obes Surg 2004;14:1157-1164. Doi: http://dx.doi. org/10.1381/0960892042387057
National Institutes of Health. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 1992;55:(Supl l):615S-619S.
Logue J, Thompson L, Romanes F, Wilson DC, Thompson J, Sattar N. Management of obesity: summary of SIGN guideline. BMJ 2010;340:c154. doi:10.1136/bmj.c154
Fried M, Hainer V, Basdevant A, Buchwald H, Dietel M, Finer N, et al. Interdisciplinary guidelines on Surgery of Severe (Morbid) Obesity. Int J Obes 2007;31:569-577. doi:10.1038/sj.ijo.0803560
National Institute of Health and Clinical Excellence (NICE) Clinical Guidelines. Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children. National Institute for Health and Clinical Excellence. London, 2006.
Thomas CM, Taub LFM. Monitoring for and preventing the long-term sequelae of bariatric surgery. J Am Acad Nurse Pract 2011;23:449-458. DOI: 10.1111/j.1745- 7599.2011.00655.x
O’Brien PE, McPhail T, Chaston TB, Dixon JB. Systematic Review of Medium-Term Weight Loss after Bariatric Operations. Obes Surg 2006;16:1032-1040.
Doggrell SA, Chan V. Bariatric surgery or medicine for type 2 diabetes? Expert Opin Pharmacother 2012;13:2249-2253. Doi:10.1517/14656566.2012.721779
Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes. N Engl J Med 2012;366:1577-1585. DOI: 10.1056/NEJMoa1200111
Kashyap SR, Bhatt DL, Schauer PR. STAMPEDE Investigators. Bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: rationale and design of the Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently trial (STAMPEDE). Diabetes Obes Metab 2010;12:452-454. Doi: 10.1111/j.1463-1326.2009.01172.x
Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes. N Engl J Med 2012;26;366:1567-1576. DOI:10.1056/NEJMoa1200225
Ikramuddin S, Korner J, Lee WJ, Connett JE, Inabnet WB, Billington CJ, et al. Roux-en-Y Gastric Bypass vs Intensive Medical Management for the Control of Type 2 Diabetes, Hypertension, and Hyperlipidemia. The Diabetes Surgery Study Randomized Clinical Trial. JAMA 2013;309:2240- 2249. Doi:10.1001/jama.2013.5835.
Dorman RB, Serrot FJ, Miller CJ, Slusarek BM, Sampson BK, Buchwald H, et al. Case-matched outcomes in bariatric surgery for treatment of type 2 diabetes in the morbidly obese patient. Ann Surg 2012;255:287-293.
Spector D, Shikora S. Neuro-modulation and bariatric surgery for type 2 diabetes mellitus. Int J Clin Pract 2010;64(s166):53-58.
Raghow R. Bariatric surgery-mediated weight loss and its metabolic consequences for type-2 diabetes. World J Diabetes 2013;4:47-50.
Korner J, Inabnet W, Febres G, Conwell IM, McMahon DJ, Salas R, et al. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes 2009;33:786-795.
Rutledge T, Adler S, Friedman R. A Prospective Assessment of Psychosocial Factors Among Bariatric Versus Non-bariatric Surgery Candidates. Obes Surg 2011;21:1570-1579.
Walfish S, Vance D, Fabricatore AN. Psychological Evaluation of Bariatric Surgery Applicants: Procedures and Reasons for Delay or Denial of Surgery. Obes Surg 2007;17:1578-1583.
Zimmerman M, Francione-Witt C, Chelminski I, Young D, Boerescu D, Attiullah N, et al. Presurgical psychiatric evaluations of candidates for bariatric surgery, Part 1: Reliability and reasons for and frequency of exclusion. J Clin Psychiatry 2007;68:1557-1562.
Kinzl JF, Schrattenecker M, Traweger C, Mattesich M, Fiala M, Biebl W. Psychosocial Predictors of Weight Loss after Bariatric Surgery. Obes Surg 2006;16:1609-1614.
Livhits M, Mercado C, Yermilov I, Parikh JA, Dutson E, Mehran A, et al. Preoperative Predictors of Weight Loss Following Bariatric Surgery: Systematic Review. Obes Surg 2012;22:70-89.